Growth Metrics

TELA Bio (TELA) Cost of Revenue (2018 - 2026)

TELA Bio has reported Cost of Revenue over the past 8 years, most recently at $7.0 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 124.84% year-over-year to $7.0 million; the TTM value through Dec 2025 reached $47.1 million, up 367.17%, while the annual FY2025 figure was $25.6 million, 13.92% up from the prior year.
  • Cost of Revenue for Q4 2025 was $7.0 million at TELA Bio, up from $6.6 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $33.0 million in Q4 2022 and troughed at -$28.3 million in Q4 2024.
  • A 5-year average of $5.3 million and a median of $5.9 million in 2024 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: plummeted 263.13% in 2021 and later skyrocketed 417.53% in 2022.
  • Year by year, Cost of Revenue stood at -$10.4 million in 2021, then skyrocketed by 417.53% to $33.0 million in 2022, then tumbled by 174.34% to -$24.6 million in 2023, then decreased by 15.08% to -$28.3 million in 2024, then surged by 124.84% to $7.0 million in 2025.
  • Business Quant data shows Cost of Revenue for TELA at $7.0 million in Q4 2025, $6.6 million in Q3 2025, and $16.9 million in Q2 2025.